Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02175303
What this trial is testing

A Pilot Study Using Placenta Derived Decidual Stromal Cells for Toxicity and Inflammation With Special Focus to the Allogeneic Hematopoietic Cell Transplantation Setting

Who this might be right for
Acute Lung InjuryDecidual Stromal CellsStem Cell Transplantation+1 more
Karolinska Institutet 25
Testing effectiveness (Phase 2)UnknownNCT03146468
What this trial is testing

Nivolumab for Relapsed or Residual Haematological Malignancies After Allogeneic Stem Cell Transplantation

Who this might be right for
Haematological Malignancy
Melbourne Health 14
Large-scale testing (Phase 3)Study completedNCT01015261
What this trial is testing

Allogenic Bone Marrow Transplantation (BMT) Compare With Cytoreduction and Chemotherapy in Acute Lymphoblastic Leukemia (ALL) Patients

Who this might be right for
Acute Lymphoblastic Leukemia
Tehran University of Medical Sciences 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115
What this trial is testing

Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
City of Hope Medical Center 260
Testing effectiveness (Phase 2)Study completedNCT04014790
What this trial is testing

RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Graft Vs Host DiseaseGraft-versus-host-diseaseAcute-graft-versus-host Disease+1 more
Regimmune Corporation 49
Not applicableUnknownNCT03148197
What this trial is testing

Changes in the Gut Microbiota of Patients Undergoing Allogeneic Stem Cell Transplantation (COLLECT)

Who this might be right for
Acute Myeloid LeukemiaGraft-versus-host-diseaseAllogeneic Hematopoietic Stem Cell Transplantation+1 more
University of Cologne 120
Testing effectiveness (Phase 2)UnknownNCT00998361
What this trial is testing

Hematopoietic Stem Cell Transplantation From Human Leukocyte Antigen (HLA) Compatible Donor in Ewing Sarcomas and Soft Tissues Sarcomas

Who this might be right for
EwingSoft Tissue Sarcoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 140
Testing effectiveness (Phase 2)Ended earlyNCT05799079
What this trial is testing

Decitabine and Cedazuridine in Combination With Venetoclax for the Treatment of Patients Who Have Relapsed Acute Myeloid Leukemia After Donor Stem Cell Transplant

Who this might be right for
Recurrent Acute Myeloid Leukemia
Sanjay Mohan 1
Large-scale testing (Phase 3)Looking for participantsNCT06860269
What this trial is testing

A 3-cohort Randomized Study Evaluating the Role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Frontline Therapy of Adults With Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Assistance Publique - Hôpitaux de Paris 1,200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06602323
What this trial is testing

TMLI/Fludarabine/Melphalan Conditioning for Allogeneic Transplantation in High-risk Myelodysplastic Syndrome or Acute Myeloid Leukemia.

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 34
Early research (Phase 1)Looking for participantsNCT03802695
What this trial is testing

Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesMixed Phenotype Acute Leukemia+1 more
Orca Biosystems, Inc. 300
Testing effectiveness (Phase 2)UnknownNCT05583175
What this trial is testing

Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignancies

Who this might be right for
Leukemia, Myeloid, AcuteMDSHematopoietic Stem Cell Transplantation+1 more
Xianmin Song, MD 50
Not applicableStudy completedNCT07181330
What this trial is testing

Clinical Performance of SE-SPTM-PCR in Detecting Hcmv-miR-UL22A-5p After Hematopoietic Stem Cell Transplantation

Who this might be right for
Cytomegalovirus InfectionsHematopoietic Stem Cell Transplantation (HSCT)CMV Reactivation+1 more
Ting YANG 60
Testing effectiveness (Phase 2)WithdrawnNCT05201183
What this trial is testing

A Dose Escalation Study of Intensity Modulated Total Marrow Irradiation (IMRT-TMI) Followed by Fludarabine as a Myeloablative Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed and Refractory Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaChronic Myeloid LeukemiaAcute Lymphocytic Leukemia+1 more
Naoyuki G. Saito, M.D., Ph.D.
Not applicableLooking for participantsNCT07500441
What this trial is testing

Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Peking University People's Hospital 100
Large-scale testing (Phase 3)WithdrawnNCT03066466
What this trial is testing

Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaMyelodysplastic Syndrome
Loyola University
Testing effectiveness (Phase 2)Looking for participantsNCT06529731
What this trial is testing

Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Sawa Ito, MD 57
Testing effectiveness (Phase 2)Ended earlyNCT00593645
What this trial is testing

Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
Washington University School of Medicine 7
Testing effectiveness (Phase 2)Ended earlyNCT01790295
What this trial is testing

Ruxolitinib Prior to Transplant in Patients With Myelofibrosis

Who this might be right for
Primary MyelofibrosisPost Polycythemia Vera MyelofibrosisPost Essential Thrombocythemia Myelofibrosis
John Mascarenhas 21
Testing effectiveness (Phase 2)WithdrawnNCT03851081
What this trial is testing

Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientBlasts 5 Percent or More of Bone Marrow Nucleated CellsBlasts 5 Percent or More of Peripheral Blood White Cells+5 more
Roswell Park Cancer Institute
Next Page